Section
Regulatory
FDA, DEA, state boards, warning letters and policy.
- 08:20The Chicago Crusader
State Medicaid Program to Begin Covering GLP-1 Weight Loss Drugs
- 06:07inkl
Commentary urges platforms to curb peptide promotion on social media
- 00:44The Washington Post
Washington Post Tracks Escalating Fight Over GLP-1 Coverage
- Sep 16CBS News
CBS: companies illegally sell unapproved Lilly drug retatrutide online
- Sep 16Forbes
Forbes questions Wegovy's path into Medicare Part D coverage
- Sep 16Devdiscourse
Unapproved Peptide Treatments Spread as Safety Concerns Mount
- Sep 15fda.gov.ph
Philippine FDA warns against unauthorized Jansassy peptide skincare serum
- Sep 15Health and Me
Unapproved 'Wolverine' peptide use surges amid RFK Jr. backing
- Sep 15Investing.com
Reuters: Use of Untested 'Wolverine' Peptide Rises, Study Finds
- Sep 15reuters.com
Study Documents Rising Use of Unapproved 'Wolverine' Peptide
- Sep 157NEWS
Counterfeit retatrutide linked to torn oesophagus, officials warn
- Sep 14PEPTI
PEPTI publishes a seven-point checklist for vetting peptide telehealth
- Sep 13abc17news.com
Report: approved peptides rest on limited human research
- Sep 12SunStar Publishing Inc.
FDA warns public against unregistered tirzepatide product
- Sep 12Nation Thailand
Thai FDA seizes peptide products worth over 52 million baht
- Sep 11MedPage Today
MedPage Today examines claims behind booming peptide market
- Sep 10findarticles.com
FDA advisers back six peptides for compounding list
- Sep 10wbay.com
Peptide therapy's growing popularity raises questions for doctors, patients